Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Linical Co., Ltd. ( (JP:2183) ) has provided an update.
Linical Co., Ltd. reported a significant decline in its financial performance for the fiscal year ending March 31, 2025, with net sales dropping by 15.2% and a net loss of ¥539 million. Despite the downturn, the company forecasts a recovery in the next fiscal year with an expected 7.3% increase in net sales and a return to profitability.
More about Linical Co., Ltd.
Linical Co., Ltd. is a company listed on the Tokyo Stock Exchange, operating in the clinical research industry. It focuses on providing services related to drug development and clinical trials, catering to the pharmaceutical and biotechnology sectors.
Average Trading Volume: 50,056
Technical Sentiment Signal: Sell
Current Market Cap: Yen6.71B
See more data about 2183 stock on TipRanks’ Stock Analysis page.